Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-20-006218
Filing Date
2020-06-12
Accepted
2020-06-12 16:54:08
Documents
22

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2273998
2 filename2.htm EX-10.1 269393
3 filename3.htm EX-10.14 445695
4 GRAPHIC g919364g10n62.jpg GRAPHIC 46237
5 GRAPHIC g919364g14p85.jpg GRAPHIC 131753
6 GRAPHIC g919364g15b83.jpg GRAPHIC 81777
7 GRAPHIC g919364g17p14.jpg GRAPHIC 83971
8 GRAPHIC g919364g28k40.jpg GRAPHIC 61928
9 GRAPHIC g919364g29k46.jpg GRAPHIC 44573
10 GRAPHIC g919364g31n67.jpg GRAPHIC 54941
11 GRAPHIC g919364g38k92.jpg GRAPHIC 129470
12 GRAPHIC g919364g48k16.jpg GRAPHIC 52174
13 GRAPHIC g919364g49b96.jpg GRAPHIC 95474
14 GRAPHIC g919364g51n14.jpg GRAPHIC 168985
15 GRAPHIC g919364g57z76.jpg GRAPHIC 62018
16 GRAPHIC g919364g67n74.jpg GRAPHIC 70127
17 GRAPHIC g919364g67y47.jpg GRAPHIC 104921
18 GRAPHIC g919364g78x14.jpg GRAPHIC 78586
19 GRAPHIC g919364g82y30.jpg GRAPHIC 45530
20 GRAPHIC g919364g87q50.jpg GRAPHIC 96902
21 GRAPHIC g919364g97b16.jpg GRAPHIC 92216
22 GRAPHIC g919364g98y16.jpg GRAPHIC 77878
  Complete submission text file 0000950123-20-006218.txt   5136423
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03163 | Film No.: 20960842
SIC: 2834 Pharmaceutical Preparations